CN
79-92-5
Applied Filters:
Keyword:'79-92-5'
Showing 1-30 of 128 results for "79-92-5" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
72 71 79 93 106
56 103 13 5 2 62 39 19 92 88 40 92 98 55 57 93 94 51 74 88 59 14
96 85 102 101 76 50 58 77 87 76 38
The Effective Use of Protein Kinase Inhibitors
72 71 79 93 106
56 103 13 5 2 62 39 19 92 88 40 92 98 55 57 93 94 51 74 88 59 14
96 85 102 101 76 50 58 77 87 76 38
Application Note - Assurance GDS - Alternative confirmation E. coli O157:H7 &Salmonella
IMS 1 mL vs.
Reference Method
CHROMID® Salmonella 79 58 5 16 84 78
RAPID’Salmonella 78 61 2 17 80 74
Salmonella ChromoSelect 81 45 18 14 99 92
All three plates 89 44 19 6
Product Information Sheet - M5639
, 208(1), 74-79 (1993).
3. John, R. A., in Photometric assays. Enzyme
Assays A Practical Approach, Eisenthal, R., and
Danson, M. J., eds., IRL Press (New York, NY:
1992), pp. 59-92.
4. Jacks
Data Sheet - R7898
least 10 isoforms of B-Raf have been
identified in adult mouse tissues in the ranges of 69-72
kD and 79-99 kD.1 B-Raf is highly expressed in brain
tissues2 and is activated by Ras3,4,. The 93-95 kD
isoforms
Data Sheet - SAB4200697
Tissue Res., 339, 463-79
(2010).
3. Ozburn AR., et al., Neuropsychopharmacology.,
38, 2393-400 (2013).
4. Nagatsu T., et al., J. Biol. Chem., 239, 2910-17
(1964).
5. Grima B., et al., Nature
Data Sheet - S1444
Anti-Sprouty-2 (N-Terminal) is developed in rabbit using
a synthetic peptide corresponding to amino acids 79-98
of mouse Sprouty 2 (Spry 2), conjugated to KLH via a
C-terminal added lysine residue as immunogen
Quality Control Range Sheet- PCC-124 and PCC-224
TGFα Control 1 63 - 131 pg/mL IL-5 Control 1 74 - 155 pg/mL
Control 2 425 - 882 pg/mL Control 2 579 - 1202 pg/mL
S(–)-Blebbistatin: Selective inhibitor ofnon-muscle myosin II
1028-1032
(1999).
5. Korenbaum, E., et al., Genomic organization and expression profile of the
parvin family of focal adhesion protens in mice and humans., Gene, 279,
69-79 (2001).
N
ew
P
FcFusionProteinSeparation
60
70
80
6.
14
0 6.
79
4
7.
47
8
7.
83
3
8.
71
8
9.
41
2
9.
92
9
10
.5
39
10
.8
13
11
.3
77
12
.0
42
12
.5
Verfication summary-03-0202-00
HMN713786
3 MRD (1:4) 35.58 1.0 3% 142.31 4.2 3% -
3 1:8 16.42 0.9 5% 131.35 6.9 5% 92%
3 1:16 8.17 0.4 5% 130.65 6.1 5% 92%
3 1:32 4.69 0.2 4% 150.01 5.8 4% 105%
Verfication summary-03-0202-00
HMN713786
3 MRD (1:4) 35.58 1.0 3% 142.31 4.2 3% -
3 1:8 16.42 0.9 5% 131.35 6.9 5% 92%
3 1:16 8.17 0.4 5% 130.65 6.1 5% 92%
3 1:32 4.69 0.2 4% 150.01 5.8 4% 105%
CDK1/CyclinA2 active (C0244)
mM
NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼79 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 78–106 nmole/min/mg (see Figure
Data Sheet - C7479
Eur. J. Biochem.,
196, 79 (1991).
3. Heizmann, C.W., Gen. Physiol. Biophys., 11, 411
(1992).
4. Baimbridge, K.G., et al., Trends Neurosci., 15, 303
(1992).
5. Chard, P.S., et al., Proc.
Impurities & Related Compounds: Reference Materials
-26-5
540-84-1
20535-83-5
149-57-5
345-92-6
874-43-1
51-78-5
123-42-2
103931-20-0
60-31-1
1466-82-6
530-75-6
121268-17-5
23828-92-4
37517-28-5
39831-55-5
Data Sheet - S6448 - Lot 031M0741
with 150 mM NaCl, 0.2 5 mM DTT, 0.1 mM
EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼100 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 79–107 nmole/min/mg (see
Data Sheet - S6448 - Lot 110M0848
with 150 mM NaCl, 0.2 5 mM DTT, 0.1 mM
EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼100 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 79–107 nmole/min/mg (see
Data Sheet - S6448 - Lot 031M0724
with 150 mM NaCl, 0.2 5 mM DTT, 0.1 mM
EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼100 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 79–107 nmole/min/mg (see
Product Information Sheet - D0627
Biochemical
Research, 3rd edition. Clarendon Press
(Oxford, UK), pp. 78-79 (1986).
28. Wilding, T.J. et al., J. Neurosci., 15(5),
4124-4132 (1995).
29. Major, T. et al., Curr. Protoc.
Data Sheet - S6448 - Lot 011M0810
with 150 mM NaCl, 0.2 5 mM DTT, 0.1 mM
EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼100 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 79–107 nmole/min/mg (see
Data Sheet - S6448 - Lot 071M0921
with 150 mM NaCl, 0.2 5 mM DTT, 0.1 mM
EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼100 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 79–107 nmole/min/mg (see
Data Sheet - S6448 - Lot 090M0847
with 150 mM NaCl, 0.2 5 mM DTT, 0.1 mM
EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼100 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 79–107 nmole/min/mg (see
Data Sheet - S6448 - Lot 100M0846
with 150 mM NaCl, 0.2 5 mM DTT, 0.1 mM
EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼100 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 79–107 nmole/min/mg (see
Data Sheet - S6448 - Lot 010M0848
glycerol.
Molecular mass: ∼100 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 79–107 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not
LABORATORY NOTEBOOK ISSUANCE PAGE
26
.9
82
28
.0
85
30
.9
74
32
.0
6
35
.4
5
39
.9
48
69
.7
23
72
.6
3
74
.9
22
78
.9
6
79
.9
04
83
.7
98
11
4.
82
11
LABORATORY NOTEBOOK ISSUANCE PAGE
26
.9
82
28
.0
85
30
.9
74
32
.0
6
35
.4
5
39
.9
48
69
.7
23
72
.6
3
74
.9
22
78
.9
6
79
.9
04
83
.7
98
11
4.
82
11
LABORATORY NOTEBOOK ISSUANCE PAGE
26
.9
82
28
.0
85
30
.9
74
32
.0
6
35
.4
5
39
.9
48
69
.7
23
72
.6
3
74
.9
22
78
.9
6
79
.9
04
83
.7
98
11
4.
82
11
Data Sheet - A6606
Molecular and cellular
pathogenesis of hemoglobin SC disease. Proc.
Natl. Acad. Sci. USA, 79, 7527-31 (1982).
5. Clark, M.R., et al., Study on the dehydrating effect
of the red cell Na+/K+-pump in nystatin-treated
Aldrich Polymer Products Application - Transitions
acrylate -26
tert-Butyl acrylate 43-107 193
2-tert-Butylaminoethyl methacrylate 33
Butyl glydicyl ether -79
Butyl methacrylate 20
tert-Butyl methacrylate 118
4-tert-Butylstyrene 127
tert-Butyl vinyl ether 88
Datasheet - A8592
Mammalian Transcription by
the 26S Proteasome”. Georgia State University,
Ph.D. dissertation, p. 79 (2009).
5. Dorn, Karolin Viktoria, “Evc2 regulates
Hedgehog Signaling at Primary Cilia”.
Heinrich-
Page 1 of 5